No products in the cart.

Chapter 25. Asthma

Pharmacotherapeutics for Advanced Practice 3rd Edition by Virginia Poole Arcangelo, Andrew M. Peterson

$2.99

Chapter 25.  Asthma

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

MULTIPLE CHOICE

 

  1. Prior to developing a plan for the treatment of asthma, the patient’s asthma should be classified according to the NHLBI Expert Panel 3 guidelines. In adults mild-persistent asthma is classified as asthma symptoms that occur:
A. Daily
B. Daily and limit physical activity
C. Less than twice a week
D. More than twice a week and less than once a day

 

 

ANS:  D                    PTS:   1

 

  1. In children age 5 to 11 years mild-persistent asthma is diagnosed when asthma symptoms occur:
A. At nighttime one to two times a month
B. At nighttime three to four times a month
C. Less than twice a week
D. Daily

 

 

ANS:  B                    PTS:   1

 

  1. One goal of asthma therapy outlined by the NHLBI Expert Panel 3 guidelines is:
A. Ability to use albuterol daily to control symptoms
B. Minimize exacerbations to once a month
C. Keep nighttime symptoms at a maximum of twice a week
D. Require infrequent use of beta 2 agonists (albuterol) for relief of symptoms

 

 

ANS:  D                    PTS:   1

 

  1. A stepwise approach to the pharmacologic management of asthma:
A. Begins with determining the severity of asthma and assessing asthma control
B. Is used when asthma is severe and requires daily steroids
C. Allows for each provider to determine their personal approach to the care of asthmatic patients
D. Provides a framework for the management of severe asthmatics, but is not as helpful when patients have intermittent asthma

 

 

ANS:  A                    PTS:   1

Additional information

Add Review

Your email address will not be published. Required fields are marked *